enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Eliezer Masliah - Wikipedia

    en.wikipedia.org/wiki/Eliezer_Masliah

    These allegations involved crucial studies related to Alzheimer's and Parkinson's disease, particularly surrounding the alpha-synuclein protein. [ 1 ] The dossier was sent to the HHS Office of Research Integrity , which requested that the National Institute on Aging (NIA) start a research misconduct investigation in May 2023. [ 11 ]

  3. Category:Deaths from Alzheimer's disease in Israel - Wikipedia

    en.wikipedia.org/wiki/Category:Deaths_from...

    Pages in category "Deaths from Alzheimer's disease in Israel" The following 2 pages are in this category, out of 2 total. This list may not reflect recent changes. A.

  4. Ali Rezai (neurosurgeon) - Wikipedia

    en.wikipedia.org/wiki/Ali_Rezai_(neurosurgeon)

    Ali R. Rezai (born 1965) [1] is an Iranian-born American neurosurgeon and neuroscientist. [2] [3] His work and research has focused on neuromodulation treatments for patients with neurological and mental health conditions, [4] including neuromodulation techniques such as deep brain stimulation (DBS) through brain chip implants to treat Parkinson's disease tremors, obsessive–compulsive ...

  5. Chevy's emotional holiday ad features a grandmother with ...

    www.aol.com/lifestyle/chevys-emotional-holiday...

    As Majoros told Ad Age, reminiscence therapy is not intended as a “cure or a solve” for Alzheimer’s and other memory-loss conditions, but it can “enable the person going through it to feel ...

  6. Aducanumab - Wikipedia

    en.wikipedia.org/wiki/Aducanumab

    Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. [2] [3] It is a monoclonal antibody [3] [2] that targets aggregated forms (plaque) [4] [5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [6] [7] It was developed by Biogen and Eisai. [8]

  7. Who is eligible for the new FDA-approved Alzheimer's drug? - AOL

    www.aol.com/lifestyle/explainer-eligible-fda...

    Because it is a disease of aging, most Alzheimer's patients are covered by Medicare, which had effectively denied coverage of Leqembi under the accelerated approval it received in January. The ...

  8. Sylvain Lesné - Wikipedia

    en.wikipedia.org/wiki/Sylvain_Lesné

    The paper, "A specific amyloid-β protein assembly in the brain impairs memory", suggested the Aβ*56 oligomer (known as amyloid beta star 56 and Abeta*56) [15] as a cause of Alzheimer's disease. [12] [23] The study proposed that Aβ*56 was responsible for the memory deficits that occur in Alzheimer's. [22]

  9. Mark A. Smith - Wikipedia

    en.wikipedia.org/wiki/Mark_A._Smith

    Smith served on the Professional Advisory Board of the Cleveland chapter of the Alzheimer's Association and was Team Captain of a group of local researchers ("A Cure From Cleveland") that participates in the annual fund raising Memory Walk for the Alzheimer's Association. In addition, Smith donated his time as a frequent guest speaker at local ...